Company / AR per Share
Viridian Therapeutics, Inc.\DE AR per Share History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.05
FY2019
5-year range
-
FY2016-FY2019
Trend
+6276.0%
vs FY2018
Sector context
#98 of 113
Health Care
What the data says
AR per Share changed +6276% YoY in FY2019, a notable deviation from the 3-year average annual change of +4089%.
Based on SEC 10-K filings.
0.05 in FY2019 with a 3-year CAGR of +22.4%.
Declined from $1.75 to $0.05 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +22.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 113This company $0.05 Sector average $28.83
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2019, ar per share increased 6276.0% year-over-year.
- Ranks #98 out of 113 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $0.05 | +6276.0% |
| FY2018 | $0.00 | -100.0% |
| FY2017 | $1.75 | +6091.0% |
| FY2016 | $0.03 | -72.9% |
As of FY2019 · SEC 10-K · Updated Jun 30, 2026